{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:05:06Z","timestamp":1768835106069,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100007687","name":"Swedish Medical Society","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Reinhold Sund Foundation"},{"name":"\u00d6sterg\u00f6tland County Council"},{"DOI":"10.13039\/501100007230","name":"Stiftelsen Konung Gustaf V:s Jubileumsfond","doi-asserted-by":"publisher","award":["FAI-2014-0025"],"award-info":[{"award-number":["FAI-2014-0025"]}],"id":[{"id":"10.13039\/501100007230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1014-1","type":"journal-article","created":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T23:40:04Z","timestamp":1464046804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Circulating secretory IgA antibodies against cyclic citrullinated peptides in early rheumatoid arthritis associate with inflammatory activity and smoking"],"prefix":"10.1186","volume":"18","author":[{"given":"Karin","family":"Roos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klara","family":"Martinsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Ziegelasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yngve","family":"Sommarin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Sv\u00e4rd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Skogh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alf","family":"Kastbom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van \u2019t Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43:1831\u20135.","journal-title":"Arthritis Rheum."},{"key":"1014_CR2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","volume":"62","author":"O Snir","year":"2010","unstructured":"Snir O, Widhe M, Hermansson M, von Spee C, Lindberg J, Hensen S, et al. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients. Arthritis Rheum. 2010;62:44\u201352.","journal-title":"Arthritis Rheum."},{"key":"1014_CR3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.coi.2013.09.018","volume":"25","author":"VM Holers","year":"2013","unstructured":"Holers VM. Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis. Curr Opin Immunol. 2013;25:728\u201335.","journal-title":"Curr Opin Immunol."},{"key":"1014_CR4","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MM Nielen","year":"2004","unstructured":"Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380\u20136.","journal-title":"Arthritis Rheum."},{"key":"1014_CR5","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741\u20139.","journal-title":"Arthritis Rheum."},{"key":"1014_CR6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/ard.2003.016808","volume":"63","author":"A Kastbom","year":"2004","unstructured":"Kastbom A, Strandberg G, Lindroos A, Skogh T. Anti-CCP antibody test predicts the disease course during 3\u00a0years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis. 2004;63:1085\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR7","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J R\u00f6nnelid","year":"2005","unstructured":"R\u00f6nnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, et al. Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5\u00a0year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis. 2005;64:1744\u20139.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/0022034513483142","volume":"92","author":"S Kaur","year":"2013","unstructured":"Kaur S, White S, Bartold PM. Periodontal disease and rheumatoid arthritis: a systematic review. J Dent Res. 2013;92:399\u2013408.","journal-title":"J Dent Res."},{"key":"1014_CR9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.38348","volume":"66","author":"TR Mikuls","year":"2014","unstructured":"Mikuls TR, Payne JB, Yu F, Thiele GM, Reynolds RJ, Cannon GW, et al. Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66:1090\u2013100.","journal-title":"Arthritis Rheumatol."},{"key":"1014_CR10","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3899\/jrheum.091323","volume":"37","author":"CA Hitchon","year":"2010","unstructured":"Hitchon CA, Chandad F, Ferucci ED, Willemze A, Ioan-Facsinay A, van der Woude D, et al. Antibodies to Porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives. J Rheumatol. 2010;37:1105\u201312.","journal-title":"J Rheumatol."},{"key":"1014_CR11","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1186\/ar4289","volume":"15","author":"SL Arvikar","year":"2013","unstructured":"Arvikar SL, Collier DS, Fisher MC, Unizony S, Cohen GL, McHugh G, et al. Clinical correlations with Porphyromonas gingivalis antibody responses in patients with early rheumatoid arthritis. Arthritis Res Ther. 2013;15:R109.","journal-title":"Arthritis Res Ther."},{"key":"1014_CR12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jre.12002","volume":"48","author":"GP Harvey","year":"2013","unstructured":"Harvey GP, Fitzsimmons TR, Dhamarpatni AASSK, Marchant C, Haynes DR, Bartold PM. Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anti-citrullinated protein antibodies in human gingiva. J Periodontal Res. 2013;48:252\u201361.","journal-title":"J Periodontal Res."},{"key":"1014_CR13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.imbio.2012.04.011","volume":"218","author":"A Sv\u00e4rd","year":"2013","unstructured":"Sv\u00e4rd A, Kastbom A, Sommarin Y, Skogh T. Salivary IgA antibodies to cyclic citrullinated peptides (CCP) in rheumatoid arthritis. Immunobiology. 2013;218:232\u20137.","journal-title":"Immunobiology."},{"key":"1014_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54:38\u201346.","journal-title":"Arthritis Rheum."},{"key":"1014_CR15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/ard.2009.114694","volume":"69","author":"P Stolt","year":"2010","unstructured":"Stolt P, Yahya A, Bengtsson C, K\u00e4llberg H, R\u00f6nnelid J, Lundberg I, et al. Silica exposure among male current smokers is associated with a high risk of developing ACPA-positive rheumatoid arthritis. Ann Rheum Dis. 2010;69:1072\u20136.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR16","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/art.39170","volume":"67","author":"A Sv\u00e4rd","year":"2015","unstructured":"Sv\u00e4rd A, Skogh T, Alfredsson L, Ilar A, Klareskog L, Bengtsson C, et al. Associations to smoking and shared epitope differ between IgA and IgG class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis. Arthritis Rheumatol. 2015;67:2032\u20137.","journal-title":"Arthritis Rheumatol."},{"key":"1014_CR17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.38201","volume":"66","author":"G Reynisdottir","year":"2014","unstructured":"Reynisdottir G, Karimi R, Joshua V, Olsen H, Hensvold AH, Harju A, et al. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol. 2014;66:31\u20139.","journal-title":"Arthritis Rheumatol."},{"key":"1014_CR18","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1002\/art.38066","volume":"65","author":"VC Willis","year":"2013","unstructured":"Willis VC, Demoruelle MK, Derber LA, Chartier-Logan CJ, Parish MC, Pedraza IF, et al. Sputum autoantibodies in patients with established rheumatoid arthritis and subjects at risk of future clinically apparent disease. Arthritis Rheum. 2013;65:2545\u201354.","journal-title":"Arthritis Rheum."},{"key":"1014_CR19","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1136\/annrheumdis-2013-204912","volume":"74","author":"AJ Ytterberg","year":"2015","unstructured":"Ytterberg AJ, Joshua V, Reynisdottir G, Tarasova NK, Rutishauser D, Ossipova E, et al. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: identification and validation. Ann Rheum Dis. 2015;74:1772\u20137.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR20","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.34344","volume":"64","author":"MK Demoruelle","year":"2012","unstructured":"Demoruelle MK, Weisman MH, Simonian PL, Lynch DA, Sachs PB, Pedraza IF, et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? Arthritis Rheum. 2012;64:1756\u201361.","journal-title":"Arthritis Rheum."},{"key":"1014_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0889-857X(05)70024-7","volume":"24","author":"DE Trentham","year":"1998","unstructured":"Trentham DE. Oral tolerization as a treatment of rheumatoid arthritis. Rheum Dis Clin North Am. 1998;24:525\u201336.","journal-title":"Rheum Dis Clin North Am."},{"key":"1014_CR22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pharep.2013.09.007","volume":"66","author":"I Doro\u017cy\u0144ska","year":"2014","unstructured":"Doro\u017cy\u0144ska I, Majewska-Szczepanik M, Marci\u0144ska K, Szczepanik M. Partial depletion of natural gut flora by antibiotic aggravates collagen induced arthritis (CIA) in mice. Pharmacol Rep. 2014;66:250\u20135.","journal-title":"Pharmacol Rep."},{"key":"1014_CR23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.immuni.2010.06.001","volume":"32","author":"WHJ Ivanov II","year":"2010","unstructured":"Ivanov II WHJ, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32:815\u201327.","journal-title":"Immunity."},{"key":"1014_CR24","first-page":"1500","volume":"35","author":"J Vaahtovuo","year":"2008","unstructured":"Vaahtovuo J, Munukka E, Korkeam\u00e4ki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35:1500\u20135.","journal-title":"J Rheumatol."},{"issue":"10 Suppl","key":"1014_CR25","first-page":"S518","volume":"64","author":"S Dalvi","year":"2012","unstructured":"Dalvi S, Scher JU, Attur M, Patel J, Abramson SB. Elevated fecal secretory immunoglobulin A, anti-cyclic citrullinated peptide antibodies, and cytokine levels in rheumatoid arthritis patients [abstract 1212]. Arthritis Rheum. 2012;64(10 Suppl):S518.","journal-title":"Arthritis Rheum"},{"key":"1014_CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4049\/jimmunol.105.1.43","volume":"105","author":"RH Waldman","year":"1970","unstructured":"Waldman RH, Mach JP, Stella MM, Rowe DS. Secretory IgA in human serum. J Immunol. 1970;105:43\u20137.","journal-title":"J Immunol."},{"key":"1014_CR27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fimmu.2013.00222","volume":"4","author":"P Brandtzaeg","year":"2013","unstructured":"Brandtzaeg P. Secretory IgA: designed for anti-microbial defense. Front Immunol. 2013;4:222.","journal-title":"Front Immunol."},{"key":"1014_CR28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2249.2008.03616.x","volume":"152","author":"JW Eijgenraam","year":"2008","unstructured":"Eijgenraam JW, Oortwijn BD, Kamerling SWA, De Fijter JW, Van Den Wall Bake AWL, Daha MR, et al. Secretory immunoglobulin A (IgA) responses in IgA nephropathy patients after mucosal immunization, as part of a polymeric IgA response. Clin Exp Immunol. 2008;152:227\u201332.","journal-title":"Clin Exp Immunol."},{"key":"1014_CR29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/ard.2005.041376","volume":"65","author":"E Berglin","year":"2006","unstructured":"Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis. 2006;65:453\u20138.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/ard.2003.019992","volume":"64","author":"E Lindqvist","year":"2005","unstructured":"Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis. 2005;64:196\u2013201.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/rheumatology\/kei240","volume":"45","author":"VF Manfredsdottir","year":"2006","unstructured":"Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson O, Heimisdottir M, et al. The effects of tobacco smoking and rheumatoid factor seropositivity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford). 2006;45:734\u201340.","journal-title":"Rheumatology (Oxford)"},{"key":"1014_CR32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/rheumatology\/34.3.236","volume":"34","author":"C Jorgensen","year":"1995","unstructured":"Jorgensen C, Moynier M, Bologna C, Youinou P, Sany J. Rheumatoid factor associated with a secretory component in rheumatoid arthritis. Br J Rheumatol. 1995;34:236\u201340.","journal-title":"Br J Rheumatol."},{"key":"1014_CR33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/03009742.2014.930926","volume":"44","author":"E Hallert","year":"2015","unstructured":"Hallert E, Husberg M, Kalkan A, Rahmqvist M, Skogh T, Bernfort L. Changes in sociodemographic characteristics at baseline in two Swedish cohorts of patients with early rheumatoid arthritis diagnosed 1996\u201398 and 2006\u201309. Scand J Rheumatol. 2015;44:100\u20135.","journal-title":"Scand J Rheumatol."},{"key":"1014_CR34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315\u201324.","journal-title":"Arthritis Rheum."},{"key":"1014_CR35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van \u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44\u20138.","journal-title":"Arthritis Rheum"},{"key":"1014_CR36","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/03009748809098795","volume":"17","author":"C Ekdahl","year":"1988","unstructured":"Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis: use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988;17:263\u201371.","journal-title":"Scand J Rheumatol."},{"key":"1014_CR37","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/03009740310004748","volume":"33","author":"AR Olsson","year":"2004","unstructured":"Olsson AR, Skogh T, Wingren G. Aetiological factors of importance for the development of rheumatoid arthritis. Scand J Rheumatol. 2004;33:300\u20136.","journal-title":"Scand J Rheumatol."},{"key":"1014_CR38","first-page":"1974","volume":"22","author":"A Larsen","year":"1995","unstructured":"Larsen A. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol. 1995;22:1974\u20135.","journal-title":"J Rheumatol."},{"key":"1014_CR39","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1136\/ard.62.9.835","volume":"62","author":"P Stolt","year":"2003","unstructured":"Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L, et al. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case\u2013control study, using incident cases. Ann Rheum Dis. 2003;62:835\u201341.","journal-title":"Ann Rheum Dis."},{"key":"1014_CR40","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1186\/ar2449","volume":"10","author":"A Sv\u00e4rd","year":"2008","unstructured":"Sv\u00e4rd A, Kastbom A, Reckner-Olsson A, Skogh T. Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project. Arthritis Res Ther. 2008;10:R75.","journal-title":"Arthritis Res Ther."},{"key":"1014_CR41","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2177\/jsci.26.346","volume":"26","author":"K Iwasaki","year":"2003","unstructured":"Iwasaki K, Okawa-Takatsuji M, Aotsuka S, Ono T. Detection of anti-SS-A\/Ro and anti-SS-B\/La antibodies of IgA and IgG isotypes in saliva and sera of patients with Sj\u00f6gren\u2019s syndrome. Nihon Rinsho Meneki Gakkai Kaishi. 2003;26:346\u201354.","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi."},{"key":"1014_CR42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cei.12769","volume":"184","author":"C Sandin","year":"2016","unstructured":"Sandin C, Eriksson P, Segelmark M, Skogh T, Kastbom A. IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis. Clin Exp Immunol. 2016;184:208\u201315.","journal-title":"Clin Exp Immunol."},{"key":"1014_CR43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1084\/jem.20071204","volume":"205","author":"T Matysiak-Budnik","year":"2008","unstructured":"Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, Lebreton C, M\u00e9nard S, Candalh C, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med. 2008;205:143\u201354.","journal-title":"J Exp Med."},{"key":"1014_CR44","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.172.5.3026","volume":"172","author":"J Rey","year":"2004","unstructured":"Rey J, Garin N, Spertini F, Corthesy B. Targeting of secretory IgA to Peyer\u2019s patch dendritic and T cells after transport by intestinal M cells. J Immunol. 2004;172:3026\u201333.","journal-title":"J Immunol."},{"key":"1014_CR45","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.4049\/jimmunol.175.5.2793","volume":"175","author":"L Favre","year":"2005","unstructured":"Favre L, Spertini F, Corthesy B. Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses. J Immunol. 2005;175:2793\u2013800.","journal-title":"J Immunol."},{"key":"1014_CR46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF02238549","volume":"15","author":"D Wendling","year":"1996","unstructured":"Wendling D, Didier JM, Seilles E. Serum secretory immunoglobulins in ankylosing spondylitis. Clin Rheumatol. 1996;15:590\u20133.","journal-title":"Clin Rheumatol."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1014-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T01:50:43Z","timestamp":1718589043000},"score":1,"resource":{"primary":{"URL":"http:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1014-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1014-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]},"article-number":"119"}}